Literature DB >> 21832277

IL-12 selectively programs effector pathways that are stably expressed in human CD8+ effector memory T cells in vivo.

Fatema Z Chowdhury1, Hilario J Ramos, Laurie S Davis, James Forman, J David Farrar.   

Abstract

CD8(+) cytotoxic T lymphocytes play a major role in defense against intracellular pathogens, and their functions are specified by antigen recognition and innate cytokines. IL-12 and IFN-α/β are potent "signal 3" cytokines that are involved in both effector and memory cell development. Although the majority of effector cells are eliminated as inflammation resolves, some survive within the pool of memory cells and retain immediate effector function. In this study, we demonstrate that IL-12 instructs a unique program of effector cell differentiation that is distinct from IFN-α/β. Moreover, effector memory (T(EM)) cells within peripheral blood display many common attributes of cells differentiated in vitro in response to IL-12, including proinflammatory cytokine secretion and lytic activity. A pattern of IL-12-induced genes was identified that demarcate T(EM) from central memory cells, and the ontologies of these genes correlated precisely with their effector functions. Further, we uncovered a unique program of gene expression that was acutely regulated by IL-12 and reflected in stable gene expression patterns within T(EM), but not T central memory cells in vivo. Thus, this study directly links a selective set of IL-12-induced genes to the programming of effector functions within the stable population of human CD8(+) T(EM) cells in vivo.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21832277      PMCID: PMC3193266          DOI: 10.1182/blood-2011-05-357111

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

1.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Authors:  F Sallusto; D Lenig; R Förster; M Lipp; A Lanzavecchia
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

2.  Molecular and functional profiling of memory CD8 T cell differentiation.

Authors:  Susan M Kaech; Scott Hemby; Ellen Kersh; Rafi Ahmed
Journal:  Cell       Date:  2002-12-13       Impact factor: 41.582

3.  Lineage relationship and protective immunity of memory CD8 T cell subsets.

Authors:  E John Wherry; Volker Teichgräber; Todd C Becker; David Masopust; Susan M Kaech; Rustom Antia; Ulrich H von Andrian; Rafi Ahmed
Journal:  Nat Immunol       Date:  2003-02-03       Impact factor: 25.606

4.  The roles of IL-12 in providing a third signal for clonal expansion of naive CD8 T cells.

Authors:  Javier Valenzuela; Clint Schmidt; Matthew Mescher
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

5.  The EMT regulator Zeb2/Sip1 is essential for murine embryonic hematopoietic stem/progenitor cell differentiation and mobilization.

Authors:  Steven Goossens; Viktor Janzen; Sonia Bartunkova; Tomomasa Yokomizo; Benjamin Drogat; Mihaela Crisan; Katharina Haigh; Eve Seuntjens; Lieve Umans; Tamara Riedt; Pieter Bogaert; Lieven Haenebalcke; Geert Berx; Elaine Dzierzak; Danny Huylebroeck; Jody J Haigh
Journal:  Blood       Date:  2011-02-25       Impact factor: 22.113

6.  Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells.

Authors:  Susanne J Szabo; Brandon M Sullivan; Claudia Stemmann; Abhay R Satoskar; Barry P Sleckman; Laurie H Glimcher
Journal:  Science       Date:  2002-01-11       Impact factor: 47.728

7.  Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions.

Authors:  Nathalie Rufer; Alfred Zippelius; Pascal Batard; Mikael J Pittet; Isabel Kurth; Patricia Corthesy; Jean-Charles Cerottini; Serge Leyvraz; Eddy Roosnek; Markus Nabholz; Pedro Romero
Journal:  Blood       Date:  2003-05-15       Impact factor: 22.113

8.  Control of effector CD8+ T cell function by the transcription factor Eomesodermin.

Authors:  Erika L Pearce; Alan C Mullen; Gislâine A Martins; Connie M Krawczyk; Anne S Hutchins; Valerie P Zediak; Monica Banica; Catherine B DiCioccio; Darrick A Gross; Chai-An Mao; Hao Shen; Nezih Cereb; Soo Y Yang; Tullia Lindsten; Janet Rossant; Christopher A Hunter; Steven L Reiner
Journal:  Science       Date:  2003-11-07       Impact factor: 47.728

9.  Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function.

Authors:  Julie M Curtsinger; Debra C Lins; Matthew F Mescher
Journal:  J Exp Med       Date:  2003-05-05       Impact factor: 14.307

10.  Restoration of CD28 expression in CD28- CD8+ memory effector T cells reconstitutes antigen-induced IL-2 production.

Authors:  Max S Topp; Stanley R Riddell; Yoshiki Akatsuka; Michael C Jensen; Joseph N Blattman; Philip D Greenberg
Journal:  J Exp Med       Date:  2003-09-08       Impact factor: 14.307

View more
  31 in total

1.  IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques.

Authors:  Rashmi Jalah; Vainav Patel; Viraj Kulkarni; Margherita Rosati; Candido Alicea; Brunda Ganneru; Agneta von Gegerfelt; Wensheng Huang; Yongjun Guan; Kate E Broderick; Niranjan Y Sardesai; Celia LaBranche; David C Montefiori; George N Pavlakis; Barbara K Felber
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

2.  Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cells.

Authors:  Khrishen Cunnusamy; Ethan J Baughman; Jorge Franco; Sterling B Ortega; Sushmita Sinha; Parul Chaudhary; Benjamin M Greenberg; Elliot M Frohman; Nitin J Karandikar
Journal:  Clin Immunol       Date:  2014-03-20       Impact factor: 3.969

3.  Absence of recipient C3aR1 signaling limits expansion and differentiation of alloreactive CD8+ T cell immunity and prolongs murine cardiac allograft survival.

Authors:  Douglas R Mathern; Julian K Horwitz; Peter S Heeger
Journal:  Am J Transplant       Date:  2019-01-14       Impact factor: 8.086

4.  Serine protease inhibition attenuates rIL-12-induced GZMA activity and proinflammatory events by modulating the Th2 profile from estrogen-treated mice.

Authors:  Ebru Karpuzoglu; Chad W Schmiedt; Julian Pardo; Megan Hansen; Tai L Guo; Steven D Holladay; Robert M Gogal
Journal:  Endocrinology       Date:  2014-05-19       Impact factor: 4.736

Review 5.  New insights into IL-12-mediated tumor suppression.

Authors:  S Tugues; S H Burkhard; I Ohs; M Vrohlings; K Nussbaum; J Vom Berg; P Kulig; B Becher
Journal:  Cell Death Differ       Date:  2014-09-05       Impact factor: 15.828

6.  Antigen availability determines CD8⁺ T cell-dendritic cell interaction kinetics and memory fate decisions.

Authors:  Sarah E Henrickson; Mario Perro; Scott M Loughhead; Balimkiz Senman; Susanne Stutte; Michael Quigley; Gabriela Alexe; Matteo Iannacone; Michael P Flynn; Shaida Omid; Jonathan L Jesneck; Sabrina Imam; Thorsten R Mempel; Irina B Mazo; W Nicholas Haining; Ulrich H von Andrian
Journal:  Immunity       Date:  2013-09-19       Impact factor: 31.745

7.  Allograft dendritic cell p40 homodimers activate donor-reactive memory CD8+ T cells.

Authors:  Hidetoshi Tsuda; Charles A Su; Toshiaki Tanaka; Katayoun Ayasoufi; Booki Min; Anna Valujskikh; Robert L Fairchild
Journal:  JCI Insight       Date:  2018-02-22

Review 8.  Bystander T Cells: A Balancing Act of Friends and Foes.

Authors:  Sarah K Whiteside; Jeremy P Snook; Matthew A Williams; Janis J Weis
Journal:  Trends Immunol       Date:  2018-11-06       Impact factor: 16.687

9.  Ex vivo conditioning with IL-12 protects tumor-infiltrating CD8+ T cells from negative regulation by local IFN-γ.

Authors:  Lin Lin; Patricia Rayman; Paul G Pavicic; Charles Tannenbaum; Thomas Hamilton; Alberto Montero; Jennifer Ko; Brian Gastman; James Finke; Marc Ernstoff; C Marcela Diaz-Montero
Journal:  Cancer Immunol Immunother       Date:  2018-12-14       Impact factor: 6.968

10.  IFN-α suppresses GATA3 transcription from a distal exon and promotes H3K27 trimethylation of the CNS-1 enhancer in human Th2 cells.

Authors:  Jonathan P Huber; Sarah R Gonzales-van Horn; Kole T Roybal; Michelle A Gill; J David Farrar
Journal:  J Immunol       Date:  2014-05-09       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.